Kallya

Levonorgestrel, the active ingredient in Kallya, is a progestin presented as an oral tablet for oral use. It is used as an emergency contraceptive to prevent pregnancy after unprotected intercourse.

GNH USA supplies Kallya as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levonorgestrel is a progestin that acts within the hormonal pathway of contraception.

- Emergency contraception: prevents pregnancy when taken after unprotected sexual intercourse. - Post‑coital contraception: provides a high dose to inhibit or delay ovulation. - Pregnancy prevention: used as a single‑dose regimen to reduce the risk of fertilization.

Levonorgestrel may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea - Abdominal pain - Fatigue - Headache - Dizziness - Menstrual changes

Serious or Rare Side Effects: - Allergic reaction (rash, swelling, anaphylaxis) - Severe abdominal pain - Chest pain or palpitations - Severe headache or migraine - Blood clots (deep vein thrombosis, pulmonary embolism) - Liver dysfunction (elevated enzymes).

When using Kallya, several safety considerations should be observed.

- Allergy: avoid if known hypersensitivity to levonorgestrel or excipients. - Pregnancy: not indicated for ongoing pregnancy; confirm a negative pregnancy test before use. - Timing: must be taken within 72 hours of unprotected intercourse for optimal efficacy. - Drug interactions: effectiveness may be reduced by enzyme‑inducing medications. - Medical conditions: caution in women with active liver disease or thromboembolic disorders. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levonorgestrel can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Rifampicin, carbamazepine, phenytoin: strong enzyme inducers that lower levonorgestrel levels. - St. John’s wort: herbal inducer reducing effectiveness.

Moderate Interactions (Monitor Closely): - Ketoconazole (antifungal): may increase levonorgestrel exposure. - Efavirenz (antiretroviral): may modestly reduce efficacy. - Valproate (anticonvulsant): potential interaction requiring monitoring.